Medical News

RSS

Automated software solution for H1N1 preparation

San Diego-based Concerro, Inc., the market leader in enterprise-wide hospital shift and emergency workforce management software, is pleased to announce the launch of PanFluAware™, an automated software solution and decision making system for H1N1 preparation and response. A free webcast demonstration will be held on Friday, September 25th at 1:00 PM eastern standard time.

23 Sep 2009

CPS expands business, adds a remote order entry services division

Comprehensive Pharmacy Services (CPS) announced today a significant expansion of its business, adding a remote order entry services division. CPS’ new division will offer remote prescription approval and order entry to the healthcare industry and will be branded as RemoteSolutions, a CPS company.

23 Sep 2009

Results of IES presented at ECCO

Pfizer Inc today announced new, longer-term data from the Intergroup Exemestane Study (IES) showing that women who switched to AROMASIN® (exemestane tablets) after taking tamoxifen for two to three years experienced a significant reduction (18%) in the risk of disease-free survival (DFS) events. In addition, IES showed that AROMASIN prolonged overall survival (OS) in the ER+/unknown population with a 14% reduction in the risk of dying. These results demonstrate that the benefits of treatment are maintained in long term follow-up. These results were presented at the joint ECCO 15/ESMO 34 meeting in Berlin, Germany.

23 Sep 2009

Celera and Medco collaborate in KIF6 gene variant testing

Celera Corporation (NASDAQ:CRA) and Medco Health Solutions, Inc. (NYSE:MHS), today announced that they have entered into a research collaboration to evaluate whether testing for a gene variant called KIF6 increases patient adherence with statin therapy. Current studies have suggested that only about 50 to 60 percent of the patients who receive a prescription for a lipid-lowering drug are taking the medication after six months.

23 Sep 2009

Pricing of secondary offering announced by Bruker Corporation

Bruker Corporation (NASDAQ: BRKR) today announced the pricing of an underwritten secondary offering of 13,000,000 shares of its common stock at a price to the public of $9.85 per share.

23 Sep 2009

Some abortion-rights advocates find health debate disheartening

"For some abortion-rights activists, the debate over health care reform has been frustrating, even disheartening, as they see their political allies on the defensive and their anti-abortion rivals on the attack," The Associated Press reports.

23 Sep 2009

Professional and personal distress levels high in primary care physicians

Primary care physicians who participated in an educational program that included an emphasis on mindful communication reported improvement in personal well-being, emotional exhaustion, empathy and attitudes associated with patient-centered care, according to a study in the September 23/30 issue of JAMA, a theme issue on medical education.

23 Sep 2009

Proposed cuts can impact Ohio's health care services

The health reform bill currently pending in the House of Representatives, combined with the impact of the cuts being waved in front of Medicare-funded nursing homes -- an estimated $12 billion over 10 years -- will find Ohio's seniors in need of nursing and rehabilitative care on shaky ground.

23 Sep 2009

ADRS to improve consumer care by using Starbak's enterprise video platform

Starbak (http://www.starbak.com/), the leading provider of enterprise video portals and integrated networks for the Education, Corporate, Healthcare and Government markets, today announced that Alabama Department of Rehabilitation Services (ADRS) is using its award-winning enterprise video platform (http://www.starbak.com/solutions/Starbak_V3_Video_Portal_and_Integrated_Network/solutions.aspx) to improve consumer care by providing its geographically dispersed rehabilitation professionals with access to targeted and timely on-demand skills training videos.

23 Sep 2009

Bio-Path Holdings to develop liposome tumor targeting technology

Bio-Path Holdings, Inc. (OTCBB: BPTH), a publicly traded biotechnology company with drug development operations in Houston, Texas, announced today the Company has executed an exclusive license with The University of Texas M. D. Anderson Cancer Center to develop liposome tumor targeting technology. Bio-Path is currently developing a neutral-lipid based liposome delivery technology for nucleic acid cancer drugs (including antisense and siRNA molecules).

23 Sep 2009

$Using moldable pastes to repair fractures in the future$

Using moldable pastes to repair fractures in the future

New stem cell studies at the University of Maryland Dental School demonstrate that surgeons could one day routinely use strong, moldable, and injectable pastes to regenerate needed bone tissue to repair broken bones, fractures, genetic defects, even combat bone wounds.

23 Sep 2009

New method to diagnose active tuberculosis

Active tuberculosis can be rapidly identified in patients with negative sputum tests by a new method, according to European researchers. Active tuberculosis (TB) is the seventh-leading cause of death worldwide, and while the diagnosis of active TB can be rapidly established when the bacteria can be identified on sputum microscopy, in about half of all cases, the TB bacterium cannot be detected, making another diagnostic option critical in efforts to control the spread of TB.

23 Sep 2009

Community Hospital South implements GE Healthcare's Centricity Enterprise solution

GE Healthcare, a leading provider of healthcare information technology, announced Community Hospital South (Indianapolis) is now live with GE Centricity™ Enterprise 6.1 and Monitored Care, an integrated clinical, financial and administrative solution that helps streamline workflow and improve productivity across the continuum of care.

23 Sep 2009

Medical students post unprofessional content online

A majority of medical schools surveyed report they have experienced incidents of students posting unprofessional content online, including incidents involving violation of patient confidentiality, with few schools having policies to address these types of postings, according to a study in the September 23/30 issue of JAMA, a theme issue on medical education.

23 Sep 2009

Hyperthermia with chemotherapy prolongs survival

BSD Medical Corporation (NASDAQ:BSDM) reports that significant and “medical practice changing” clinical study results were the subject of a news briefing at Europe’s largest cancer congress, ECCO15 – ESMO34, which is being held September 20 to 24, 2009, in Berlin, Germany.

23 Sep 2009

Researching the causes of Alzheimer's disease

The standard explanation for what causes Alzheimer's is known as the amyloid hypothesis, which posits that the disease results from of an accumulation of the peptide amyloid beta, the toxic protein fragments that deposit in the brain and become the sticky plaques that have defined Alzheimer's for more than 100 years.

23 Sep 2009

Sterile cord blood collection bag now from PacifiCord

Dedicated to serving the private cord blood banking needs of Southern California, PacifiCord (www.pacificord.com) today announced it has secured Pall Corporation’s sterile cord blood collection bag. Since April 2006, this industry-best sterile bag has been unavailable for purchase due to prior limiting agreements with its manufacturer; no longer.

23 Sep 2009

Former senior manager sentenced for defrauding Hitachi America Group Health and Welfare Plan

Preet Bharara, the U.S. Attorney for the Southern District of New York, announced that Dennis M. Dowd, formerly the senior manager of human resources of Hitachi America Ltd. (Hitachi America), was sentenced today in Manhattan federal court to 57 months in prison for defrauding the Hitachi America Group Health and Welfare Plan (the Plan) of more than $6 million.

23 Sep 2009

Report on species-crossing microbes and H1N1

Significant weaknesses undermine the global community's abilities to prevent, detect early, and respond efficiently to potentially deadly species-crossing microbes, such as the pandemic H1N1 influenza virus sweeping the globe, says a new report from the Institute of Medicine and National Research Council. The report provides a detailed plan for establishing and funding a comprehensive, globally coordinated system to identify novel zoonotic disease threats as early as possible wherever they arise so appropriate measures can be taken to prevent significant numbers of human illnesses and deaths, and livestock losses.

23 Sep 2009

NIH grants $3.4M to develop tools for identification of prostate cancer using MRI

Rutgers University and two collaborators have received a $3.4 million research grant to develop tools aimed at improving the identification of prostate cancer using MRI, or magnetic resonance imaging.

23 Sep 2009